ANTI-CD2 AND ANTI-CD3 MONOCLONAL ANTIBODIES SYNERGIZE TO PROLONG ALLOGRAFT SURVIVAL WITH DECREASED SIDE EFFECTS.

Autor: Chavin, Kenneth D., Qin, Lihui, Lin, Jixun, Kaplan, Adam J., Bromberg, Jonathan S.
Zdroj: Transplantation; Apr1993, Vol. 55 Issue 4, p901-908, 8p
Databáze: Complementary Index